News|Slideshows|April 30, 2025

April Pharmaceutical Industry Movers & Shakers

A monthly roundup of business and people news in the pharmaceutical industry.

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Trending on PharmExec

April Pharmaceutical Industry Movers & Shakers

Related Content

Pharmaceutical Executive Daily: FDA Approves Datroway

FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates

Director of NIH Infectious Disease Institute Steps Down

The Biotech Industry’s Relationship with Real-Time Data: Q&A with Dr. Richard Graham

Modern Communication Between FDA, Biotech, and Investors: Q&A with David Crean

Trending on PharmExec

The Biotech Industry’s Relationship with Real-Time Data: Q&A with Dr. Richard Graham

Does FDA's Shift From Two Pivotal Trials to One Represent a Genuine Evolution?

FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates

Director of NIH Infectious Disease Institute Steps Down

Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report